Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 05 symbols : AZN save search
Global Asthma and COPD Drugs Market Report to 2030 - Opportunity Analysis and Industry Forecasts
Published: 2022-05-05 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: 0.46%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -0.86%
H: 1.57%
C: -0.42%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: -1.61%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -1.35%
H: 0.4%
C: -1.2%
report market drug
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -1.35%
H: 0.4%
C: -1.2%
enhertu approved cancer breast cancer her2- her2 metastatic breast cancer
ENHERTU® Approved in the U.S. for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -1.35%
H: 0.4%
C: -1.2%
enhertu approved positive cancer breast cancer her2- her2 metastatic breast cancer
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.